Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Implications of Palliative Care Screening in Outpatient Comprehensive Cancer Genome Profiling Tests
Banri Tsuda1, Yuko Ohnuki2,3, Hiromi Tomomatsu1
1Department of Palliative Care Medicine, Tokai University School of Medicine, Tokai University School of Medicine, Isehara, Kanagawa Prefecture, Japan.
Cancer patients undergoing Comprehensive Cancer Genome Profiling (CGP) often experience significant physical and psychological distress. Despite this, many do not access palliative care services, highlighting a critical gap in supportive oncology care.
Area of Science:
- Oncology
- Palliative Care
- Genomics
Background:
- Patients with cancer frequently experience distress during Comprehensive Cancer Genome Profiling (CGP).
- Access to palliative care services is not universally utilized by distressed cancer patients undergoing CGP.
Purpose of the Study:
- To assess the prevalence of physical and emotional distress in cancer patients who underwent CGP testing.
- To evaluate the utilization of palliative care services among these patients.
Main Methods:
- The Ease of Living Questionnaire was used to assess distress levels.
- Data were collected from 75 patients attending a CGP outpatient clinic between November 2022 and July 2023.
Main Results:
- 16% of patients reported significant physical symptoms (≥3/5), with 5 visiting palliative care.
- 28% of patients reported significant psychological symptoms (≥6/10), with only 8 visiting palliative care.
Conclusions:
- A substantial number of patients undergoing CGP experience distress, indicating a need for palliative care integration.
- Current palliative care utilization is low, suggesting opportunities to improve patient referrals from CGP clinics.
- CGP outpatient clinics can play a role in identifying and connecting patients with necessary palliative care support.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11:02Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Related Concept Videos
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...